Elligo expands research network with oncology center partnership

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/LewisTsePuiLung)
(Image: Getty/LewisTsePuiLung)

Related tags: Elligo Health Research, Clinical research, Research, Clinical trial, Partnership, Breast cancer, Oncology

Elligo expands its Research Ready network and adds its first oncology practice through a partnership with Austin Cancer Center, which is currently enrolling patients for breast cancer studies.

The health research organization, Elligo, will work with the Austin Cancer Center (ACC) to add its clinical research network,while ACC’s oncologists will offer research as a care option.

Mary Costello, VP of clinic development and patient advocacy at Elligo told us, “Most research starts at academic medical centers and standalone research dedicated practices. By partnering with health care providers in the community, Elligo helps extend access and expand the reach of the study itself.”

According to ACC, the partnership enables its patients to remain under its care while receiving opportunities to participate in clinical studies through Elligo’s Research Ready network. The network operates on its Goes Direct approach connecting patients and sites to research studies across the industry.

Costello said Elligo selected to work with physicians in Austin, TX, the 11th​ largest city in the US, “to allow cancer patients the opportunity to access clinical research in their own community, which increases the likelihood they will participate and extends the chance to participate to all patients, not just those fortunate enough to be able to travel outside of their community.”

ACC currently offers clinical care across medical oncology, comprehensive breast care and breast oncology, gynecologic oncology, radiation oncology, neuro-oncology, and diagnostic and interventional radiology specialties.

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars